Lumida
/EHTH
⌘K
eHealth Inc

eHealth Inc

EHTH
$0.93USD+1.13%+0.01 today

MARKET CAP

29.9M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$6

AI Summary

Stalk
Sell NowMedium

EHTH is in a Stage 4 decline with confirmed lower highs and lower lows, trading below declining EMAs that act as resistance. Medium-term asymmetry remains bearish, and short-term timing is bearish as price tightly tracks under sloping EMAs. Execution should occur now via a rejection at the 9/20/50 EMA cluster. A sustained close and acceptance above the EMA zone and a subsequent higher swing high would invalidate this bearish medium-term bias.

  • Lifetime advisory model launched to drive higher retention and upsells
  • Operating cash flow improved by $36M y/y, now –$5M vs –$41.2M
  • Q2 revenue collapsed 45% y/y to $33.6M on lower Medicare Advantage volume
Full analysis →

Buying

6

institutions

Selling

2

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
AC

Aqr Capital Management LLC

Q2 2026

BUY2.29 M3.41 M+573.30 K+54.1%0.00%
BI

Blackrock, Inc.

Q2 2026

SELL1.34 M2.00 M+-1.35 M-42.4%0.00%
EP

Eversept Partners, LP

Q2 2026

BUY404.85 K603.23 K+183.94 K+111.7%0.03%
MM

Millennium Management LLC

Q2 2026

BUYNEW247.91 K369.39 K+247.91 K+0.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY238.07 K354.72 K+200.97 K+641.2%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY31.80 K46.74 K+12.76 K+88.9%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL16.20 K24.14 K+-8.90 K-25.4%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW13.53 K20.16 K+13.53 K+0.0%0.00%